ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EKSO Ekso Bionics Holdings Inc

1.4281
-0.0119 (-0.83%)
Pre Market
Last Updated: 13:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ekso Bionics Holdings Inc NASDAQ:EKSO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0119 -0.83% 1.4281 1.39 1.43 500 13:00:00

Initial Statement of Beneficial Ownership (3)

20/03/2020 10:14pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Combest Development (Hong Kong) Ltd
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/2/2020 

3. Issuer Name and Ticker or Trading Symbol

EKSO BIONICS HOLDINGS, INC. [EKSO]
(Last)        (First)        (Middle)

ROOM 2210, CC WU BUILDING 302, HENNESSY ROAD, WAN CHAI
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

HONG KONG, K3 999077      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 8918898 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Combest Development (Hong Kong) Ltd
ROOM 2210, CC WU BUILDING 302
HENNESSY ROAD, WAN CHAI
HONG KONG, K3 999077

X


Signatures
By: /s/ Hailiang Feng, in his capacity as President of Combest Development (Hong Kong) Limited3/20/2020
**Signature of Reporting PersonDate

1 Year Ekso Bionics Chart

1 Year Ekso Bionics Chart

1 Month Ekso Bionics Chart

1 Month Ekso Bionics Chart

Your Recent History

Delayed Upgrade Clock